Skip to content
DraconiticResearch
Search Sources API
186,125 studies31 sourcesUpdated 37 min ago
Peer-reviewedCC BY 4.0Scientific Reports

Reference intervals for neutrophil reactive oxygen species production capacity in Japanese adults

Abstract

Innate immunity provides the first line of defense against pathogens; however, quantitative benchmarks for assessing its function remain limited. We developed optical sensing systems that enable real-time measurement of neutrophil reactive oxygen species (ROS) production by simply diluting 3 µL of whole blood into a reaction mixture. Here, we estimated reference intervals for innate immune responses of circulating neutrophils in healthy Japanese adults, primarily those in their 40s–60s, using these optical platforms. Neutrophil superoxide production and hypochlorous acid production (myeloperoxidase activity) were measured simultaneously following chemical stimulation. Data were obtained from 329 rigorously screened individuals selected from 7,263 participants (predominantly Japanese) who underwent comprehensive health examinations between February 2020 and March 2025. Reference intervals were calculated for six neutrophil activity indices, including total ROS production, ROS production per unit neutrophils, balance between the two ROS species, and neutrophil responsiveness to stimulation. Two corresponding hypochlorous acid-related indices obtained using simplified optical systems were also evaluated. Although the existence of sex-based differences in neutrophil activity indices remains unclear, sex-specific reference intervals were calculated for indices showing statistically significant sex differences and the observed differences are discussed from the perspective of future research. We further examined relationships among the indices, and their associations with age and conventional inflammatory markers. These findings provide an assay-specific quantitative framework for assessing innate immune function and may support future studies on subclinical immune variation. The gap between the current laboratory-based assay and broader clinical application, as well as future challenges, are also discussed.

Related

  1. CD300a Blockade attenuates renal fibrosis by enhancing macrophage efferocytosis and neutrophil MMP9 production
    J. Lee, C. Nakahashi-Oda, H. Koizumi +3
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I production
    Rishov Mukhopadhyay, Simeon D. Draganov, Timo Oosenbrug +12
    Nature CommunicationsPeer-reviewedCC BY-NC-ND9 citedImmunologyOpenAlex
  3. Neutrophil degranulation and extracellular ROS production are inactivated by Yersinia pseudotuberculosis YopE through a SKAP2 independent pathway
    Pathricia Angel Leus, Claudia Mañan Mejias, Alison Ren +5
    mBioPeer-reviewedCC BY 4.0Full textImmunologyCrossref
  4. Effects of chlorogenic acid on production performance, antioxidant capacity and intestinal microbiota of quails exposed to cold stress
    Chunhua Wang, Hongxin Sun, Guoxu Liang +5
    Poultry SciencePeer-reviewedCC BY-NC-ND 4.0Full textZoology & animal behaviourPMC
  5. Reproductive Efficiency: The Economics of Calving Intervals and Distributions
    Angela M. Gonella-Diaza, Kalyn Waters, Hannah Baker
    EDISPeer-reviewedCC BY-NC-NDFull textPlant biologyDOAJ
BibTeX
@article{takeuchi2026reference,
  title = {{Reference intervals for neutrophil reactive oxygen species production capacity in Japanese adults}},
  author = {Kozo Takeuchi and Naoya Hattori and Kumi Akita and Yukiko Hatano and Rie Makise and Chikako Inoguchi and Akiko Sugiho and Tomomi Shinke and Hiroshi Yoshida and Kimiko Kazumura},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-75336-z},
  url = {https://www.nature.com/articles/s41598-026-75336-z},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Reference intervals for neutrophil reactive oxygen species production capacity in Japanese adults
AU  - Kozo Takeuchi
AU  - Naoya Hattori
AU  - Kumi Akita
AU  - Yukiko Hatano
AU  - Rie Makise
AU  - Chikako Inoguchi
AU  - Akiko Sugiho
AU  - Tomomi Shinke
AU  - Hiroshi Yoshida
AU  - Kimiko Kazumura
PY  - 2026
DA  - 2026/10/26
JO  - Scientific Reports
DO  - 10.1038/s41598-026-75336-z
UR  - https://www.nature.com/articles/s41598-026-75336-z
AB  - Innate immunity provides the first line of defense against pathogens; however, quantitative benchmarks for assessing its function remain limited. We developed optical sensing systems that enable real-time measurement of neutrophil reactive oxygen species (ROS) production by simply diluting 3 µL of whole blood into a reaction mixture. Here, we estimated reference intervals for innate immune responses of circulating neutrophils in healthy Japanese adults, primarily those in their 40s–60s, using these optical platforms. Neutrophil superoxide production and hypochlorous acid production (myeloperoxidase activity) were measured simultaneously following chemical stimulation. Data were obtained from 329 rigorously screened individuals selected from 7,263 participants (predominantly Japanese) who underwent comprehensive health examinations between February 2020 and March 2025. Reference intervals were calculated for six neutrophil activity indices, including total ROS production, ROS production per unit neutrophils, balance between the two ROS species, and neutrophil responsiveness to stimulation. Two corresponding hypochlorous acid-related indices obtained using simplified optical systems were also evaluated. Although the existence of sex-based differences in neutrophil activity indices remains unclear, sex-specific reference intervals were calculated for indices showing statistically significant sex differences and the observed differences are discussed from the perspective of future research. We further examined relationships among the indices, and their associations with age and conventional inflammatory markers. These findings provide an assay-specific quantitative framework for assessing innate immune function and may support future studies on subclinical immune variation. The gap between the current laboratory-based assay and broader clinical application, as well as future challenges, are also discussed.
SN  - 2045-2322
ER  -